Skip to main content

Site notifications

AusPAR: Evolocumab

Australian Public Assessment Report
Device/Product Name
Repatha
Active ingredients
Evolocumab
AusPAR Date
Published
Submission Number
PM-2017-02229-1-3
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site